The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma
- PMID: 25741453
- PMCID: PMC4346158
- DOI: 10.1093/nsr/nwu038
The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma
Abstract
In contrast to a majority of cancer types, the initiation of hepatocellular carcinoma (HCC) is intimately associated with a chronically diseased liver tissue, with one of the most prevalent etiological factors being hepatitis B virus (HBV). Transformation of the liver in HBV-associated HCC often follows from or accompanies long-term symptoms of chronic hepatitis, inflammation and cirrhosis, and viral load is a strong predictor for both incidence and progression of HCC. Besides aiding in transformation, HBV plays a crucial role in modulating the accumulation and activation of both cellular components of the microenvironment, such as immune cells and fibroblasts, and non-cellular components of the microenvironment, such as cytokines and growth factors, markedly influencing disease progression and prognosis. This review will explore some of these components and mechanisms to demonstrate both underlying themes and the inherent complexity of these interacting systems in the initiation, progression, and metastasis of HBV-positive HCC.
Keywords: cytokines; growth factors; hepatitis B; hepatocellular carcinoma; leukocytes; tumor microenvironment.
Figures
Similar articles
-
Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma.Microb Pathog. 2019 Mar;128:184-194. doi: 10.1016/j.micpath.2019.01.004. Epub 2019 Jan 3. Microb Pathog. 2019. PMID: 30611768 Review.
-
Chronic hepatitis B virus infection in Asian countries.J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. doi: 10.1046/j.1440-1746.2000.0150121356.x. J Gastroenterol Hepatol. 2000. PMID: 11197043 Review.
-
What can we learn from hepatitis B virus clinical cohorts?Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716. Liver Int. 2015. PMID: 25529093 Review.
-
Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma.Gut. 2019 May;68(5):916-927. doi: 10.1136/gutjnl-2018-316510. Epub 2018 Jul 3. Gut. 2019. PMID: 29970455
-
Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma.Liver Int. 2015 Jul;35(7):1786-800. doi: 10.1111/liv.12773. Epub 2015 Feb 9. Liver Int. 2015. PMID: 25640596 Review.
Cited by
-
Inhibition of hepatitis B virus replication by quercetin in human hepatoma cell lines.Virol Sin. 2015 Aug;30(4):261-8. doi: 10.1007/s12250-015-3584-5. Epub 2015 Aug 8. Virol Sin. 2015. PMID: 26268473 Free PMC article.
-
Somatic mutation profiling of liver and biliary cancer by targeted next generation sequencing.Oncol Lett. 2018 Nov;16(5):6003-6012. doi: 10.3892/ol.2018.9371. Epub 2018 Aug 29. Oncol Lett. 2018. PMID: 30344748 Free PMC article.
-
Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.Oncotarget. 2016 Feb 9;7(6):7241-52. doi: 10.18632/oncotarget.6892. Oncotarget. 2016. PMID: 26769845 Free PMC article. Clinical Trial.
-
Transcriptome analysis creates a new era of precision medicine for managing recurrent hepatocellular carcinoma.World J Gastroenterol. 2023 Feb 7;29(5):780-799. doi: 10.3748/wjg.v29.i5.780. World J Gastroenterol. 2023. PMID: 36816628 Free PMC article. Review.
-
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review.Cancers (Basel). 2024 May 28;16(11):2042. doi: 10.3390/cancers16112042. Cancers (Basel). 2024. PMID: 38893164 Free PMC article. Review.
References
-
- Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65–73. - PubMed
-
- Chen CJ, Yang HI, Iloeje UH, The REVEAL-HBV Study Group Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology. 2009;49:S72–84. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources